Hyaluronic Acid and Chondroitin Sulfate Help Protect Against Osteoarthritis
Author Information
Author(s): Ma Yiran, Yang Xin, Jiang Min, Ye Wangjuan, Qin Hong, Tan Songwen
Primary Institution: Aunobel Pty Ltd Nutrition and Health Research Institute, Strathfield, Australia; Monash Suzhou Research Institute, Monash University, Suzhou, China
Hypothesis
This study investigates the impact of hyaluronic acid and chondroitin sulfate on extracellular matrix degradation in osteoarthritis and the underlying mechanisms.
Conclusion
Hyaluronic acid and chondroitin sulfate mitigate ECM degradation in osteoarthritis by inhibiting the NF-κB pathway.
Supporting Evidence
- HA and CS treatments significantly reduced cartilage damage and inflammatory factor release.
- The combination of HA and CS further enhanced therapeutic effects.
- Benefits were reversed when PMA was introduced, indicating the role of the NF-κB pathway.
Takeaway
Hyaluronic acid and chondroitin sulfate can help protect the cartilage in joints affected by osteoarthritis, making it less likely to get damaged.
Methodology
The study used a rat model of osteoarthritis and treated the rats with hyaluronic acid and chondroitin sulfate, analyzing cartilage tissue for damage and inflammatory factors.
Participant Demographics
Forty 6-week-old male SD rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website